Rezolute (RZLT) Return on Capital Employed Growth (1y) (2014 - 2026)
Rezolute (RZLT) Return on Capital Employed Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,015.37 Bn | 1,015.37 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.39 Bn | 466.59 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.52 Bn | 115.28 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.33 Bn | 61.58 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 2,400.00 |
| 10 | Rezolute | 513.96 Mn | 513.96 Mn | - | 1,289.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,289.00 |
| Dec 31, 2025 | 384.00 |
| Sep 30, 2025 | 674.00 |
| Jun 30, 2025 | 513.00 |
| Mar 31, 2025 | -1,310.00 |
| Dec 31, 2024 | -571.00 |
| Sep 30, 2024 | -401.00 |
| Jun 30, 2024 | -2,474.00 |
| Mar 31, 2024 | -3,147.00 |
| Dec 31, 2023 | -3,097.00 |
| Sep 30, 2023 | -2,623.00 |
| Jun 30, 2023 | -669.00 |
| Mar 31, 2023 | 1,203.00 |
| Dec 31, 2022 | 2,656.00 |
| Sep 30, 2022 | 4,140.00 |
| Jun 30, 2022 | 2,539.00 |
| Mar 31, 2022 | 1,075.00 |
| Dec 31, 2021 | 3,663.00 |
| Sep 30, 2021 | 23,212.00 |
| Jun 30, 2021 | 14,966.00 |